Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
It is the aim of this prospective one arm phase III clinical study to evaluate recurrence in postmenopausal patients with breast cancer during 24 months of Letrozole treatment. · Rate of patients without recurrence after 24 months of Letrozole treatment.
Critère d'inclusion
- Primary breast cancer in postmenopausal patients